Turing Pharmaceuticals CEO defends Daraprim price hike – CBS News
When Turing Pharmaceuticals bought a 62-year-old drug called Daraprim in August, the company immediately raised the price of one pill from $13.50 to $750. The increase drew protests in the medical community from those concerned that many patients will no longer be able to afford the drug. Don Dahler spoke to Turing CEO Martin Shkreli, who says the move is simply a smart business decision.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.